Reposting with corrections.
The funding deal is not an MOU.
A debt finance binding term sheet was signed.
The parties can not get out of it. It is legally binding.
The USD150m funding is to cover engineering, procurement, construction and finance.
The company is generating work packages to come up with the final price tag.
It would be highly likely less than USD150m, which is conservatively estimated in the PFS.
The end game is getting closer and will be serious.
- Forums
- ASX - By Stock
- ESIA and Mining License
Reposting with corrections. The funding deal is not an MOU. A...
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
Add MNS (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online